We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$345M
AUM Growth
-$28.9M
Cap. Flow
-$37.9M
Cap. Flow %
-10.97%
Top 10 Hldgs %
29.4%
Holding
780
New
93
Increased
153
Reduced
203
Closed
29

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.68%
2 Technology 13.28%
3 Healthcare 12.33%
4 Financials 8.86%
5 Consumer Discretionary 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BR icon
601
Broadridge
BR
$19.4B
$1.19K ﹤0.01%
+9
New +$1.2K
AKBA icon
602
Akebia Therapeutics
AKBA
$250M
$1.18K ﹤0.01%
471
CNC icon
603
Centene
CNC
$33.4B
$1.17K ﹤0.01%
20
LOW icon
604
Lowe's Companies
LOW
$109B
$1.16K ﹤0.01%
7
TSLA icon
605
PUT
Tesla
TSLA
$1.41T
$1.15K ﹤0.01%
150
CDK
606
DELISTED
CDK Global, Inc.
CDK
$1.13K ﹤0.01%
26
BLK icon
607
Blackrock
BLK
$164B
$1.13K ﹤0.01%
2
HL icon
608
Hecla Mining
HL
$12.5B
$1.12K ﹤0.01%
221
EXPE icon
609
Expedia Group
EXPE
$35.2B
$1.1K ﹤0.01%
12
VIPS icon
610
Vipshop
VIPS
$5.75B
$1.09K ﹤0.01%
70
CC icon
611
Chemours
CC
$2.21B
$1.09K ﹤0.01%
52
MTN icon
612
Vail Resorts
MTN
$4.92B
$1.07K ﹤0.01%
5
AVY icon
613
Avery Dennison
AVY
$13B
$1.02K ﹤0.01%
8
AWK icon
614
American Water Works
AWK
$27.4B
$1.01K ﹤0.01%
7
DINO icon
615
HF Sinclair
DINO
$20B
$1K ﹤0.01%
51
BBBY
616
DELISTED
Bed Bath & Beyond Inc
BBBY
$1K ﹤0.01%
67
CTAS icon
617
Cintas
CTAS
$79.6B
$998 ﹤0.01%
12
HRL icon
618
Hormel Foods
HRL
$11.4B
$978 ﹤0.01%
20
CLVS
619
DELISTED
Clovis Oncology, Inc.
CLVS
$968 ﹤0.01%
166
ADAP
620
DELISTED
Adaptimmune Therapeutics
ADAP
$966 ﹤0.01%
121
UNH icon
621
UnitedHealth
UNH
$337B
$935 ﹤0.01%
3
-1,767
-100% -$543K
RARE icon
622
Ultragenyx Pharmaceutical
RARE
$1.29B
$904 ﹤0.01%
11
FAST icon
623
Fastenal
FAST
$56.7B
$902 ﹤0.01%
40
OUT icon
624
Outfront Media
OUT
$4.95B
$902 ﹤0.01%
63
CPT icon
625
Camden Property Trust
CPT
$11.9B
$890 ﹤0.01%
10

Similar funds

Exane Derivatives's Q3 2020 Portfolio in Review

As of Q3 2020, Exane Derivatives held 780 positions worth $345M, down 7.7% from $374M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Exane Derivatives withdrew a net $37.9M in Q3 2020, closing 29 positions and reducing 203 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $8.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 34% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exane Derivatives opened a new position in iShares MSCI Turkey ETF worth $10.6M.

  • Exane Derivatives's largest Q3 2020 buy was iShares MSCI Turkey ETF: 537,062 shares worth $10.6M.
  • Exane Derivatives added most to State Street Energy Select Sector SPDR ETF in Q3 2020, an estimated $15.1M increase.
  • Exane Derivatives's biggest Q3 2020 reduction was Linde, cutting an estimated $7.17M.
  • Exane Derivatives fully exited iShares MSCI Emerging Markets ETF in Q3 2020, selling an estimated $8.3M.
  • Exane Derivatives's ten largest holdings make up 29% of its $345M portfolio in Q3 2020.
  • Exane Derivatives opened 93 new positions and closed 29 in Q3 2020.
  • Exane Derivatives's portfolio value fell 7.7% quarter-over-quarter to $345M.

Based on Exane Derivatives's 13F filing for Q3 2020, filed 6 Oct 2020.